baber/WOPTO huggingface dataset:
Patent RU-2377022-C9 (RU)
Inventor: MELLER LENE
IPC: A61K9/19
Filed: 2005-01-28
Granted: 2010-08-10
Abstract: FIELD: medicine. 
     SUBSTANCE: present invention concerns medicine, specifically a powder delivery system containing a composition which contains a gelatinous or collagen powder with minimal average particle size 10 mcm. Usually, said gelatinous or collagen powder are presented in dry form, i.e. no liquid components and/or propellants are added to the composition. Besides the invention refers to the advanced powder delivery system which contains a protective structure, such as edge enclosure nearby a hole of the delivery system. The invention refers to the gelatine or collagen compositions used for haemostasis, and also to the powder delivery system including the ready-to-use gelatinous or collagen powder in the dry form. Additionally, the powder delivery system can contain a dry agent incompatible with humidity and/or water. 
     EFFECT: invention provides fast and more effective haemostasis. 
     34 cl, 10 dwg, 8 ex
Patent DK-148187-D0 (DK)
Inventor: GANCET CHRISTIAN
IPC: C12P1/00
Filed: 1987-03-23
Abstract: Process for carrying out an enzymatic reaction, in which the substrate treated is in an organic liquid which is a fluorinated hydrocarbon, which can include halogens other than fluorine.
Patent DK-207389-D0 (DK)
Inventor: MOCHIDA EI
IPC: C07D233/80
Filed: 1989-04-28
Abstract: The present invention relates to novel hydantoin derivatives, processes for producing said hydantoin derivatives, pharmaceutical compositions containing at least one of said hydantoin derivatives as aldose reductase inhibitors and novel intermediate compounds in the synthesis of said hydantoin derivatives. The present invention is based on the selection of a hydantoin which is bonded by a sulfonyl group to various substituents at the 1-position of the hydantoin skeleton. The compounds of the present invention have a strong inhibitory activity against aldose reductase. These compounds are extremely useful for the treatment and/or prevention of various forms of diabetic complications based on the accumulation of polyol metabolites.
Patent DK-208785-D0 (DK)
Inventor: BENTLEY ROBERT LEONARD
IPC: C09D5/08
Filed: 1985-05-10
Abstract: New anticorrosive compositions comprise: (A) an applicational medium selected from (a) surface coatings and (b) wholly or partly aqueous non-coating media, (B) as corrosion inhibitor, an effective corrosion-inhibiting amount of at least one aliphatic or cycloaliphatic mono-, di-, tri- or tetra-carboxylic acid ester or anhydride which is substituted in the aliphatic or cycloaliphatic residue by one or more groups having the formula    <IMAGE>  (I)   in which X is oxygen, sulphur or NH; and each R, independently, is hydrogen, alkyl, haloalkyl, alkoxy, alkylthio, alkylsulphonyl, cycloalkyl, phenyl, alkylphenyl, phenylalkyl, halogen, cyano, nitro, hydroxy, -COOH, -COOalkyl or a primary-, secondary- or tertiary amino- or carbamoyl group; or a non-toxic base addition salts of those components (B) which contain free carboxyl group.
Patent DK-261388-D0 (DK)
Inventor: HELLESTAM SVEN
IPC: B60K17/02
Filed: 1988-05-11
Abstract: A bicycle with collapsible frame, which incorporates front and rear frame posts and at least one cross-beam interconnecting said frame posts. The bicycle, which with one of a few simple hand manipulations, in a few seconds, can be folded into a compact unit. The bicycle has an absolutely rigid frame when the bicycle is in its position of use, and in collapsed position it is only little bulky with a substantial extension in one direction only. The cross-beam of the frame is a two-part cross-beam. The two parts of the cross-beam are articulatedly connected to each other and to the frame posts. The two parts of the cross-beam at folding of the frame are pivotable towards the front and the rear frame posts respectively.
Patent DK-277788-D0 (DK)
Inventor: HRUBY VICTOR J
IPC: C07K14/68
Filed: 1988-05-20
Abstract: Linear and Cyclic Alpha-MSH fragment analogues of Ac-Nle<4> - Glu<5> - His<6> - D-Phe<7> - Arg<8> - Try<9> - Gly<1><0> -NH2, The method of stimulating melanocytes by the topical application of these biologically-active analogues and compositions comprising these analogues for use in the method are disclosed:
Patent DK-542187-D0 (DK)
Inventor: FAA JR LELAND MILFORD
IPC: H05K7/20
Filed: 1987-10-16
Abstract: The present invention removably mounts a plurality of solid state devices and a circuit board to a chassis heat sink by utilizing a heat conductive device formed with a base and a leg portion with the leg portion extending from the base and having a first relatively flat surface and an angled end position. The base of the device is adapted to be mounted to a chassis heat sink and the relatively flat surface is adapted to contact one side of each of the plurality of solid state devices. A number of cap members having an inverted L-shaped cross section, with first leg portions and second leg portions are provided with an angled surface for mating with the angled end portion such that the first leg portions are substantially parallel to the first relatively flat surface. A fastener member is provided for urging the first leg portions of the cap member toward the first relatively flat surface for sandwiching the plurality of solid state devices in thermal contact with the heat conductive device and the number of cap members.
Patent HU-9201709-D0 (HU)
Title: Imidazoquinoxaline compounds, their preparation and use
Inventor: WATJEN FRANK
IPC: A61K31/495
Filed: 1990-11-22
Abstract: New imidazoquinoxaline compounds having the general formula I <IMAGE> (I)  wherein  <IMAGE>  wherein R1 and R2 independently are hydrogen, straight or branched C1-6-alkyl, or C3-7-cycloalkyl; R3 is hydrogen, straight or branched C1-6-alkyl, straight or branched C2-6-alkenyl, or aralkyl or aroylalkyl which may optionally be substituted with halogen or C1-6-alkoxy; R4 and R5 independently are hydrogen, halogen, C1-6-alkyl or trifluoromethyl. The compounds are useful in psychopharmaceutical preparations as anticonvolusants, anxiolytics, hypnotics and in improving the cognitive function of the brain of mammals.
Patent HU-902565-D0 (HU)
Title: Process for manufacturing ceramic material and metal combinations
Inventor: SCHULTZE WERNER
IPC: C04B/
Filed: 1990-04-25
Abstract: The ceramic material is built up from a plurality of layers, the layer thickness being between 10 and 15  mu m and the mean pore radius being between 100 and 1000 nm with an open porosity of 5 - 14% and a total porosity of 5 - 30%, and the metal melt being filled into the pore volume down to a residual pore volume of 0.1 - 10%, relative to the initial porosity. 
<??>It is preferably suitable for bonding to metal structures such as welded or soldered ceramic/metal constructions.
Patent HU-912674-D0 (HU)
Title: Derivatives of 1-(pyridyl-alkyl)-1h-indole or -indole and process for producing said compounds
Inventor: EFFLAND RICHARD CHARLES
IPC: C07D401/06
Filed: 1991-08-12
Abstract: This invention relates to compounds of the formula <CHEM>  wherein   R1   is hydrogen, loweralkyl, arylloweralkyl, loweralkenyl or loweralkynyl; R2   is hydrogen, lowralkyl, loweralkenyl, formyl or cyano; X   is hydrogen, halogen, nitro, amino, loweralkyl, loweralkoxy or hydroxy; Y   is hydrogen, loweralkyl, loweralkoxy, arylloweralkoxy, hydroxy, halogen, nitro or amino; the pharmaceutically acceptable acid addition salts thereof, and, where applicable, the geometric and optical isomers and racemic mixtures thereof. The compounds of the invention are useful for the treatment of various memory dysfunctions characterized by a decreased cholinergic function, such as Alzheimer's disease.
Patent NO-862948-D0 (NO)
Inventor: KEIMPEMA KEIMPE KLAAS
IPC: H03H1/00
Filed: 1986-07-22
Abstract: An overvoltage protective device specifically designed for non-symmetric transmission circuits, such as coaxial lines. A coiled section (13.1-6) of a coaxial line (8.1-6) branched off from a coaxial cable (6) wound with a number of turns is disposed within a fully closed second compartment (4) of a metal housing (1). Such a coiled section of a coaxial line together with one or more voltage-dependent current conducting components (16, 17) connected to the outer conductor of said coaxial line (8.1-6), forms a filter which effectively attenuates spurious radiation from said outer conductor at the output side of said filter, said radiation being caused by a destructive EM-pulse. The transmission characteristics of the coaxial line (8.1-6) including said coiled section (13.1-6) are not detrimentally affected by such a filter. An overvoltage protective according to the invention makes it, by its structure, feasible to lead one or more coaxial transmission lines through a wall portion of an enclosed space of the Faraday cage type, while on the other hand an effective protection is provided against destructive radiation such as caused by an EM-pulse.
Patent NO-871142-D0 (NO)
Inventor: SUNDHOLM GOERAN
IPC: B08B9/027
Filed: 1987-03-19
Abstract: PCT No. PCT/FI86/00078 Sec. 371 Date Feb. 26, 1987 Sec. 102(e) Date Feb. 26, 1987 PCT Filed Jul. 7, 1986 PCT Pub. No. WO87/00455 PCT Pub. Date Jan. 29, 1987.The present invention relates to a flushing apparatus for cleaning a piping system (2) internally. The object of the invention is to achieve efficient cleaning without the use of equipment heavily overdimensioned in relation to the nominal flow through the piping system. According to the invention, use is made of a pump (4) having an operational pressure essentially higher than the pressure fall of the piping system at a turbulent flow, in combination with at least one pressure liquid accumulator (21). The flushing circuit includes at least one blocking valve (15, 15a) which is opened upon reaching intended (maximal) pressure, thereby producing a powerful flow pulse through the piping system (2).
Patent NO-872113-D0 (NO)
Inventor: SCHULTE-FRANKENFELD MANFRED
IPC: A62C35/20
Filed: 1987-05-20
Abstract: The device has a container (13) for the extinguishing means, a pressurised gas cylinder (15) and associated fittings (20) which are arranged together in a housing which can be opened. The housing, together with the associated substructure, is now to be constructed as a compact unit and such units are to be stacked easily in a close arrangement adjacently or one above the other, simple transportation being provided by means of suitable handling equipment, in particular also for the stacking. For this purpose, the housing is essentially a cuboid container (1) having a self-supporting frame (2) which has a bottom (8) which can be gripped from below between feet (2) and stacking devices (23, 24; 31, 32). <IMAGE>
Patent NO-883516-D0 (NO)
Inventor: SCHURLE HERMANN
IPC: G02C7/02
Filed: 1988-08-08
Abstract: In order to produce the identification and/or mark, those regions on the surface of the spectacle lens (16) which represent the shape of the identification and/or mark are irradiated using an excimer laser (11) through a mask (13, 23) which contains the identification (33) and/or mark (43) as recesses (32). 
<IMAGE>
Patent NO-904542-D0 (NO)
Inventor: SEIDL RICHARD
IPC: E01H10/00
Filed: 1990-10-22
Abstract: In spreading devices with a spreading plate (1) as spreading member, which is motor-driven to rotate about an essentially vertical shaft (8) and provided with a number of essentially radially running casting shovels (15) which end at a central guide member (9), granular material to be spread is selectively supplied via a granular-material chute (11) to the guide member (9) and in this region mixed with moistening liquid. For better mixing of the media to be spread and guarantee of more uniform distribution of material to be spread, the spreading plate (1) is provided along the casing surface of the cylindrical or frustoconical guide member (9) with more than twelve impact surfaces (10) which are formed by tooth profiles of the guide member (9) or by the inner end sections of the casting shovels (15) and which, in the respective point of intersection (13) with the apex line (12) of the granular-material chute (11), form with the radial running through this point of intersection (13) an angle of incidence of approximately 40 DEG  to 60 DEG . These impact surfaces are adjoined by the casting shovels (15) in such a manner that they run in the same direction as the impact surfaces (10) at least in the inner third of the spreading plate radius. (Fig. 2) <IMAGE>
Patent NO-910753-D0 (NO)
Inventor: COMMANDEUR RAYMOND
IPC: B01J27/128
Filed: 1991-02-26
Abstract: Dielectric compositions based on benzyltoluene and (methylbenzyl)xylene, and more particularly mixtures of benzyltoluene/dibenzyltoluene with (methylbenzyl)xylene and di(methylbenzyl)xylene. These mixtures are used as low-temperature dielectric liquids.
Patent NO-911311-D0 (NO)
Inventor: VOELSTAD OVE CHARLES
IPC: F24J2/04
Filed: 1991-04-04
Abstract: The invention relates to low-energy houses and building parts (floor, tier of beams, external and internal walls, roof/ceiling) for the same. One has aimed at avoiding use of advanced technique and expensive equipment, so that the building parts (1, 2, 3, 4, 5, 5', 6, 7) themselves effect solar energy catching, transport and storage. Thus, a building part according to the invention will comprise two channel systems (e.g. 9, 10; 9', 10'; 13, 14; 13', 14') for air or other gaseous heat-carrying medium and a heat-accumulating layer, e.g. of concrete, so that the respective building part in mounted condition will exhibit an upper and a lower respectively an outer and an inner channel system.
Patent NO-911602-D0 (NO)
Inventor: BERGSTROEM SVEN
IPC: C12Q1/68
Filed: 1991-04-23
Abstract: New immunologically active fractions B, C and E of Borellia burgdorferi (B.b) are prepd. by first lysing B.b. spirochaete cells with a mild, non-denaturing detergent (I) to release outer membrane components (OMC), then cetrifuging the lysate to recover a pellet (P1) contg. cell wall and fleagellar components and supernatant (S1) contg. OMC. - (S1) is uncubated to ppte. at least sone of the proteins contained in it, then centrifuged to recover a pellet (P2), which is fraction E, and supernatant (S2). (S2) is filtered, then dialysed against low ionic strength aq. medium or ultrafiltered to remove (I) and complex B.b-derived cell components. The contents of the dialysis bag are centrifuged to give a pellet, which is fraction, B and a supernatant which is fraction C. - Also new are (1) a DNA fragment (II) encoding the 31 kD OspA protein of B.b New York Strain B31 (ATCC 35210), or its functional equivalents, and including the 5'-end of the ospA gene, and (2) antibodies (Ab) directed against fractions B, C or E or against the polypeptides encoded by (II).
Patent NO-911827-D0 (NO)
Inventor: BADSTIEBER JOHANN
IPC: E04G9/02
Filed: 1991-05-10
Abstract: PCT No. PCT/DE89/00654 Sec. 371 Date May 13, 1991 Sec. 102(e) Date May 13, 1991 PCT Filed Oct. 14, 1989 PCT Pub. No. WO90/05224 PCT Pub. Date May 17, 1990.A formwork panel has a face plate which is mounted on a frame made up of structural shapes. The panel is reinforced by a set of spaced, parallel reinforcing beams mounted on the back of the face plate. Additional beams are disposed between selected pairs of reinforcing beams. The additional beams are perpendicular to the reinforcing beams and are spaced from the frame. Each additional beam is provided with an opening which registers with a corresponding opening in the face plate. The registering openings receive tie rods which connect two facing formwork panels to one another so as to define a pouring space for concrete.
Patent NO-921134-D0 (NO)
Inventor: BROECK HENRIETTE CATHARINA VAN
IPC: A23K30/18
Filed: 1992-03-23
Abstract: Methods and expression constructs are provided for the cloning of genes from fungal origin which encode polypeptides having xylanase activity and their overexpression in a selected microbial host cell. Xylanases of fungal origin generally have lower pH optima and remain stable over a broader pH range than do xylanases of bacterial origin. The present invention provides for the high level production of fungal xylanases which are may be used in a variety of industrial applications requiring xylanase activity at a low pH.
Patent NO-930604-D0 (NO)
Inventor: WONG PATRICK S L
IPC: A61K9/22
Filed: 1993-02-22
Abstract: A dosage form is disclosed that comprises means inside the dosage form for providing a substantially drug-free interval before the dosage form delivers a drug from inside the dosage form. The dosage form in an embodiment comprises a drug on the exterior of the dosage form, which drug is available for immediate delivery.
Patent NO-941821-D0 (NO)
Inventor: RUOSLAHTI ERKKI I
IPC: A61P13/12
Filed: 1994-05-13
Abstract: The present invention provides a method of inhibiting an activity of a cell regulatory factor comprising contacting the cell regulatory factor with a purified polypeptide, wherein the polypeptide comprises the cell regulatory factor binding domain of a protein and wherein the protein is characterized by a leucine-rich repeat of about 24 amino acids. In a specific embodiment, the present invention relates to the ability of decorin, a 40,000 dalton protein that usually carries a glycosaminoglycan chain, to bind TGF- beta . The invention also provides a novel cell regulatory factor designated MRF. Also provided are methods of identifying, detecting and purifying cell regulatory factors and proteins which bind and affect the activity of cell regulatory factors. The present invention further relates to methods for the prevention or reduction of scarring by administering decorin or a functional equivalent of decorin to a wound. The methods are particularly useful for dermal wounds resulting from burns, injuries or surgery. In addition, the present invention includes pharmaceutical compositions containing decorin or its functional equivalent and a pharmaceutically acceptable carrier useful in such methods. Finally, methods for preventing or inhibiting pathological conditions by administering decorin are also provided. <IMAGE>   <IMAGE>
Patent NO-960600-D0 (NO)
Inventor: HARRELSON GLEN RAY
IPC: B65D5/462
Filed: 1996-02-15
Abstract: A basket-style carrier with means for maintaining the carrier open during loading. The carrier includes tabs foldably connected to the end panel sections at one end of the carrier. When the tabs are folded in at substantially right angles to the end panel sections, they engage a vertical support member to prevent the carrier from closing. When the articles being loaded reach the tabs, they fold the tabs up against the inside face of the end panel sections. The articles themselves maintain the carriers open at that point and the tabs are no longer needed for that purpose.
Patent NO-970218-D0 (NO)
Inventor: EHRENSPERGER MARKUS
IPC: A45D27/10
Filed: 1997-01-17
Abstract: PCT No. PCT/CH95/00165 Sec. 371 Date Jan. 29, 1997 Sec. 102(e) Date Jan. 29, 1997 PCT Filed Jul. 17, 1995 PCT Pub. No. WO96/02178 PCT Pub. Date Feb. 1, 1996Soap lather dispensers are known which process soap solution and air via a flexible arrangement in a foaming unit to produce lather. These devices are either costly to manufacture or produce lather of unreliable and/or poor quality. A uniform lather quality can be ensured independently of the actuation path (P) by a metering pump (1) which operates synchronously with the air pump (12) and has no dead spaces. With special blower units, in particular by the incorporation of the foaming unit (18) in an air chamber (17), the lather quality is further improved. The device is suitable in particular for frequent use in public washrooms.
Patent NO-974559-D0 (NO)
Inventor: RASMUSSEN OLE-BENDT
IPC: B29C49/00
Filed: 1997-10-02
Abstract: PCT No. PCT/GB93/00177 Sec. 371 Date Jun. 16, 1994 Sec. 102(e) Date Jun. 16, 1994 PCT Filed Jan. 28, 1993 PCT Pub. No. WO93/14928 PCT Pub. Date Aug. 5, 1993A cross-laminate of two or more individually stretch oriented films where the directions of orientation of the films are in criss-crossing relation, has a pattern of generally parallel elongated ribs extending lengthwise of the laminate. The ribs are defined between generally transversely coincident convex and concave curved surfaces on opposite faces of the laminate, the concave surface having a radius of curvature greater than that of the convex surface so that the ribs have a thickness greater than the average thickness of the laminate. The laminate material adjacent to lateral boundaries of the ribs is in a tensionless state reversely curved relative to the rib curvature making the material between adjacent pairs of ribs generally flat. The rib pattern is preferably regular with a preferred average transverse spacing between adjacent ribs, measured peak to peak, of about 1-10 mm. The convex surfaces of the ribs can all be on the same side of the laminate or can alternate in series between opposite sides. The pattern of elongated ribs can be interrupted at longitudinally spaced loci to enhance the flexibility of the laminate and the laminate can have an undulating curvature when viewed from the side. A process and apparatus for making the ribbed cross-laminate by means of intermeshing grooved rollers are also disclosed.
Patent NO-982876-D0 (NO)
Inventor: LEONG WILLIAM
IPC: C07C337/02
Filed: 1998-06-19
Abstract: A process for producing a hydrazide of formula (1.0) is disclosed. The process comprises reacting a hydrazone of formula (2.0) or (2.1), wherein said hydrazone is in toluene, with a mixture of Grignard reagents, wherein said Grignard reagents are in a suitable organic solvent; wherein: (A) Z is a suitable carbonyl protecting group; (B) R is a suitable -OH protecting group; (C) R<1> is selected from: H, a non-enolizable alkyl, a non-enolizable substituted alkyl, aryl, substituted aryl, -S-aryl, -S-(substituted aryl), -S-alkyl, -S-(substituted alkyl), alkoxy, substituted alkoxy, aryloxy, or substituted aryloxy; (D) said mixture of Grignard reagents comprises R<2>MgX in admixture with R<3>MgX; (E) R<2> is a suitable alkyl, substituted alkyl, alkenyl, alkynyl, aryl, substituted aryl, or aralkyl group capable of adding to the -C=N group of the hydrazone to produce the hydrazide; (F) R<3> is a suitable alkyl, substituted alkyl, aryl or substituted aryl group that is more sterically hindered than said R<2> group; (G) X is independently selected from Cl, Br or I for each Grignard reagent; (H) when said hydrazone is a compound of formula (2.0) then the reaction is conducted at a temperature of about +30 to about -40  DEG C; and (I) when said hydrazone is a compound of formula (2.1) then the reaction is conducted at a temperature of about +40 to about -20  DEG C.
Patent NO-982976-D0 (NO)
Inventor: ULRICH PETER C
IPC: A61K31/00
Filed: 1998-06-26
Abstract: The present invention relates to compositions and methods for inhibiting nonenzymatic cross-linking (protein aging) using compounds of formula (I), wherein alk is a straight or branched chain alkylene group containing from 2 to 8 carbon atoms, and R is a lower alkyl group containing from 1 to 6 carbon atoms; and their biologically or pharmaceutically acceptable acid addition salts. Accordingly, a composition is disclosed which comprises these N-acylaminoalkylhydrazinecarboximidamides, which are capable of inhibiting the formation of advanced glycosylation endproducts of target proteins. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated.